Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM. Goodman GE, et al. Among authors: crowley jj. J Clin Oncol. 1990 Jan;8(1):39-47. doi: 10.1200/JCO.1990.8.1.39. J Clin Oncol. 1990. PMID: 2153194 Clinical Trial.
Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
Kies MS, Mira JG, Crowley JJ, Chen TT, Pazdur R, Grozea PN, Rivkin SE, Coltman CA Jr, Ward JH, Livingston RB. Kies MS, et al. Among authors: crowley jj. J Clin Oncol. 1987 Apr;5(4):592-600. doi: 10.1200/JCO.1987.5.4.592. J Clin Oncol. 1987. PMID: 3031226 Clinical Trial.
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
Kelly K, Crowley JJ, Bunn PA Jr, Hazuka MB, Beasley K, Upchurch C, Weiss GR, Hicks WJ, Gandara DR, Rivkin S, et al. Kelly K, et al. Among authors: crowley jj. J Clin Oncol. 1995 Dec;13(12):2924-30. doi: 10.1200/JCO.1995.13.12.2924. J Clin Oncol. 1995. PMID: 8523056 Clinical Trial.
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Spiridonidis CH, Baker LH, Albain KS, Kelly K, Taylor SA, Gandara DR, Livingston RB. Wozniak AJ, et al. Among authors: crowley jj. J Clin Oncol. 1998 Jul;16(7):2459-65. doi: 10.1200/JCO.1998.16.7.2459. J Clin Oncol. 1998. PMID: 9667264 Clinical Trial.
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
Kelly K, Lovato L, Bunn PA Jr, Livingston RB, Zangmeister J, Taylor SA, Roychowdhury D, Crowley JJ, Gandara DR; Southwest Oncology Group. Kelly K, et al. Among authors: crowley jj. Clin Cancer Res. 2001 Aug;7(8):2325-9. Clin Cancer Res. 2001. PMID: 11489808 Clinical Trial.
427 results